Cell-Type-Dependent Thyroid Hormone Effects on Glioma Tumor Cell Lines

Abstract EN

Purpose.

The present study investigated the potential effects of long-term T3 treatment on glioma tumor cell lines.

Thyroid hormone action on cell growth, differentiation and survival during development may be of therapeutic relevance Methods and Results 1321N1 cell line, an astrocytoma grade II, and U87MG, a glioblastoma grade IV, were exposed for 2 and 4 days in medium deprived of T3 and in medium containing 1 nM T3.

T3 promoted re-differentiation in both cell lines.

However, T3 increased cell proliferation in 1321N1 (2 days) which declined thereafter (4 days) while in U87MG resulted in suppression of cell proliferation.

At the molecular level, a 2.9 fold increase in the expression of TRα1 receptor was observed in U87MG versus 1321N1, P < 0.05.

TRβ1 receptor was undetectable.

These changes corresponded to a distinct pattern of T3-induced kinase signaling activation; T3 had no effect on ERK activation in both cell lines but significantly increased phospho-Akt levels in 1321N1.

Conclusion.

In conclusion, T3 can re-differentiate glioma tumor cells, whereas its effect on cell proliferation appears to be dependent on the type of tumor cell line with aggressive tumors being more sensitive to T3.

TRα1 receptor may, at least in part, be implicated in this response.Erratum of “Cell-Type-Dependent Thyroid Hormone Effects on Glioma Tumor Cell Lines”dx.doi.org/10.1155/2012/176281